Literature DB >> 22407996

Current strategies for management of initial Clostridium difficile infection.

Ciarán P Kelly1.   

Abstract

In the past decade, an epidemic strain of Clostridium difficile has led to increased incidence and severity of nosocomial C. difficile infections (CDI). Responsiveness to standard antimicrobial care for this strain is declining, and the morbidity and mortality of CDI and recurrent CDI are rising. Effective management requires a coordinated effort among all members of the healthcare team to facilitate early identification of patients at risk for CDI, early recognition of disease onset and confirmatory testing, prompt initiation of the most appropriate management approach, and ongoing monitoring throughout the continuum of care. Hospitalists, as coordinators of patient care, are in an ideal position to ensure that patients receive prompt and optimal treatment based on current clinical evidence and severity of the disease.
Copyright © 2011 Society of Hospital Medicine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22407996     DOI: 10.1002/jhm.1909

Source DB:  PubMed          Journal:  J Hosp Med        ISSN: 1553-5592            Impact factor:   2.960


  12 in total

Review 1.  Recurrent Clostridium difficile infection: From colonization to cure.

Authors:  Kelsey Shields; Roger V Araujo-Castillo; Thimmaiah G Theethira; Carolyn D Alonso; Ciaran P Kelly
Journal:  Anaerobe       Date:  2015-04-27       Impact factor: 3.331

Review 2.  Interactions Between the Gastrointestinal Microbiome and Clostridium difficile.

Authors:  Casey M Theriot; Vincent B Young
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

3.  Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytes.

Authors:  Hon Wai Koon; David Q Shih; Tressia C Hing; Jun Hwan Yoo; Samantha Ho; Xinhua Chen; Ciarán P Kelly; Stephan R Targan; Charalabos Pothoulakis
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

Review 4.  Faecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection: current promise and future needs.

Authors:  Mark J Koenigsknecht; Vincent B Young
Journal:  Curr Opin Gastroenterol       Date:  2013-11       Impact factor: 3.287

5.  A Detrimental Role of Immunosuppressive Drug, Dexamethasone, During Clostridium difficile Infection in Association with a Gastrointestinal Microbial Shift.

Authors:  Hyeun Bum Kim; Yuankai Wang; Xingmin Sun
Journal:  J Microbiol Biotechnol       Date:  2016-03       Impact factor: 2.351

6.  Management and prevention of recurrent clostridium difficile infection in patients after total joint arthroplasty: a review.

Authors:  Benjamin E Stein; William B Greenough; Simon C Mears
Journal:  Geriatr Orthop Surg Rehabil       Date:  2012-12

7.  Overview of Clostridium difficile infection: implications for China.

Authors:  Xinhua Chen; J Thomas Lamont
Journal:  Gastroenterol Rep (Oxf)       Date:  2013-11-04

Review 8.  Clostridium difficile infection in the twenty-first century.

Authors:  Chandrabali Ghose
Journal:  Emerg Microbes Infect       Date:  2013-09-18       Impact factor: 7.163

9.  Recovery of the gut microbiome following fecal microbiota transplantation.

Authors:  Anna M Seekatz; Johannes Aas; Charles E Gessert; Timothy A Rubin; Daniel M Saman; Johan S Bakken; Vincent B Young
Journal:  MBio       Date:  2014-06-17       Impact factor: 7.867

Review 10.  Diagnostic accuracy of loop-mediated isothermal amplification in detection of Clostridium difficile in stool samples: a meta-analysis.

Authors:  Chen Wei; Liu Wen-En; Li Yang-Ming; Luo Shan; Zhong Yi-Ming
Journal:  Arch Med Sci       Date:  2015-10-12       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.